These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37795662)

  • 21. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study.
    Gharbi M; Drysdale JH; Lishman H; Goudie R; Molokhia M; Johnson AP; Holmes AH; Aylin P
    BMJ; 2019 Feb; 364():l525. PubMed ID: 30814048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCT.
    Little P; Francis NA; Stuart B; O'Reilly G; Thompson N; Becque T; Hay AD; Wang K; Sharland M; Harnden A; Yao G; Raftery J; Zhu S; Little J; Hookham C; Rowley K; Euden J; Harman K; Coenen S; Read RC; Woods C; Butler CC; Faust SN; Leydon G; Wan M; Hood K; Whitehurst J; Richards-Hall S; Smith P; Thomas M; Moore M; Verheij T
    Health Technol Assess; 2023 Jun; 27(9):1-90. PubMed ID: 37436003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and cost of chickenpox hospitalization in Thai children.
    Vandepitte WP; Chanveerachai S; Srisarang S
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S126-35. PubMed ID: 25391184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early-Life Antibiotic Exposure Associated With Varicella Occurrence and Breakthrough Infections: Evidence From Nationwide Pre-Vaccination and Post-Vaccination Cohorts.
    Lin TL; Fan YH; Chang YL; Ho HJ; Liang LL; Chen YJ; Wu CY
    Front Immunol; 2022; 13():848835. PubMed ID: 35432330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic burden of varicella in Europe in the absence of universal varicella vaccination.
    Pawaskar M; Méroc E; Samant S; Flem E; Bencina G; Riera-Montes M; Heininger U
    BMC Public Health; 2021 Dec; 21(1):2312. PubMed ID: 34930179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of health care resources for varicella in the paediatric population, Jordan.
    Abdullat M; Hayajneh W; Banni Issa A; Alshurman A; Marar B; Al-Hajajrah A; Al-Razim A; Rickard J; Rampakakis E; Altland A; Wolfson LJ
    East Mediterr Health J; 2021 Feb; 27(2):159-166. PubMed ID: 33665800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic burden of infections following intramedullary nailing for a tibial shaft fracture in England.
    Galvain T; Chitnis A; Paparouni K; Tong C; Holy CE; Giannoudis PV
    BMJ Open; 2020 Aug; 10(8):e035404. PubMed ID: 32847903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy.
    Piazza MF; Amicizia D; Paganino C; Marchini F; Astengo M; Grammatico F; Trucchi C; Romairone P; Simonetti S; Sticchi C; Ansaldi F
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States.
    Moon RC; Marijam A; Mitrani-Gold FS; Gibbons DC; Kartashov A; Rosenthal NA; Joshi AV
    PLoS One; 2022; 17(11):e0277713. PubMed ID: 36409679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.
    Pierik JG; Gumbs PD; Fortanier SA; Van Steenwijk PC; Postma MJ
    BMC Infect Dis; 2012 May; 12():110. PubMed ID: 22574722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of varicella in Germany. Potential risks and economic impact.
    Banz K; Wagenpfeil S; Neiss A; Hammerschmidt T; Wutzler P
    Eur J Health Econ; 2004 Feb; 5(1):46-53. PubMed ID: 15452764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study).
    Dinleyici EC; Kurugol Z; Turel O; Hatipoglu N; Devrim I; Agin H; Gunay I; Yasa O; Erguven M; Bayram N; Kizildemir A; Alhan E; Kocabas E; Tezer H; Aykan HH; Dalgic N; Kilic B; Sensoy G; Belet N; Kulcu NU; Say A; Tas MA; Ciftci E; Ince E; Ozdemir H; Emiroglu M; Odabas D; Yargic ZA; Nuhoglu C; Carman KB; Celebi S; Hacimustafaoglu M; Elevli M; Ekici Z; Celik U; Kondolot M; Ozturk M; Tapisiz A; Ozen M; Tepeli H; Parlakay A; Kara A; Somer A; Caliskan B; Velipasalioglu S; Oncel S; Arisoy ES; Guler E; Dalkiran T; Aygun D; Akarsu S;
    Eur J Pediatr; 2012 May; 171(5):817-25. PubMed ID: 22170238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare Resource Utilization and Costs of Steroid-Associated Complications in Patients With Graft-Versus-Host Disease.
    Bell EJ; Yu J; Bhatt V; Bunner SH; Lal LS; Galvin J; Weisdorf D
    Transplant Cell Ther; 2022 Oct; 28(10):707.e1-707.e7. PubMed ID: 35483620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions.
    Edmondson-Jones M; Dibbern T; Hultberg M; Anell B; Medin E; Feng Y; Talarico C
    Hum Vaccin Immunother; 2022 Dec; 18(1):1942712. PubMed ID: 34319865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses.
    Azzari C; Massai C; Poggiolesi C; Indolfi G; Spagnolo G; De Luca M; Gervaso P; de Martino M; Resti M
    Curr Med Res Opin; 2007 Dec; 23(12):2945-54. PubMed ID: 17937842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland.
    Heininger U; Pillsbury M; Samant S; Lienert F; Guggisberg P; Gani R; O'Brien E; Pawaskar M
    Pediatr Infect Dis J; 2021 Jun; 40(6):e217-e221. PubMed ID: 33872276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.
    Pawaskar M; Fergie J; Harley C; Samant S; Veeranki P; Diaz O; Conway JH
    PLoS One; 2022; 17(6):e0269916. PubMed ID: 35687559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Varicella complications: is it time to consider a routine varicella vaccination?].
    Dulović O; Gvozdenović E; Nikolić J; Spurnić AR; Katanić N; Kovarević-Pavićević D
    Vojnosanit Pregl; 2010 Jul; 67(7):523-9. PubMed ID: 20707045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.